Published in Infect Immun on May 01, 1992
Toll, a new piece in the puzzle of innate immunity. J Exp Med (1999) 2.36
Bacterial induction of beta interferon in mice is a function of the lipopolysaccharide component. Infect Immun (2000) 1.27
Differential contribution of Toll-like receptors 4 and 2 to the cytokine response to Salmonella enterica serovar Typhimurium and Staphylococcus aureus in mice. Infect Immun (2003) 1.22
Role of interleukin-18 (IL-18) during lethal shock: decreased lipopolysaccharide sensitivity but normal superantigen reaction in IL-18-deficient mice. Infect Immun (2000) 1.09
Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis. Infect Immun (2001) 1.08
Potentiation by granulocyte macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice. J Clin Invest (1994) 0.95
Role of T cells and gamma interferon during induction of hypersensitivity to lipopolysaccharide by toxic shock syndrome toxin 1 in mice. Infect Immun (2001) 0.94
Overexpression of Interleukin-15 increases susceptibility to lipopolysaccharide-induced liver injury in mice primed with Mycobacterium bovis bacillus Calmette-Guerin. Infect Immun (2004) 0.90
Interferon beta, a cofactor in the interferon gamma production induced by gram-negative bacteria in mice. J Exp Med (1995) 0.89
Autoinflammatory bone disorders: update on immunologic abnormalities and clues about possible triggers. Curr Opin Rheumatol (2013) 0.88
Tumor necrosis factor alpha and interleukin 6 release induced by antibiotic killing of Pseudomonas aeruginosa and Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (1997) 0.84
TLR9-dependent and independent pathways drive activation of the immune system by Propionibacterium acnes. PLoS One (2012) 0.82
Macrophage activation by lipopolysaccharide, interferon-gamma and interleukin-4: effect of fatty acid metabolism. Mediators Inflamm (1995) 0.79
Gamma interferon prevents the inhibitory effects of oxidative stress on host responses to Escherichia coli infection. Infect Immun (2001) 0.79
Stage of primary infection with lymphocytic choriomeningitis virus determines predisposition or resistance of mice to secondary bacterial infections. Med Microbiol Immunol (2006) 0.79
Beneficial or deleterious effects of a preexisting hypersensitivity to bacterial components on the course and outcome of infection. Infect Immun (2002) 0.78
TH1 cells trigger tumor necrosis factor alpha-mediated hypersensitivity to Pseudomonas aeruginosa after adoptive transfer into SCID mice. Infect Immun (1995) 0.77
Differential effects of interferon-gamma and -beta on fatty acid turnover, lipid bilayer fluidity and TNF-alpha release in murine macrophage J774.2 cells. Int J Exp Pathol (1995) 0.77
Bacterial endotoxins: biological properties and mechanisms of action. Mediators Inflamm (1993) 0.76
Carnitine and congeners as regulators of tumour necrosis factor. Mediators Inflamm (1993) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A (1975) 23.42
Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science (1985) 19.41
Shock and tissue injury induced by recombinant human cachectin. Science (1986) 16.24
Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med (1983) 14.08
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (1988) 13.42
Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med (1988) 7.96
Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci U S A (1979) 6.77
Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J Exp Med (1986) 5.09
Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J Exp Med (1984) 4.86
Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med (1987) 4.63
Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing. J Immunol (1983) 4.38
[STIMULATION OF THE PHAGOCYTIC ACTIVITY OF THE RETICULOENDOTHELIAL SYSTEM BY CORYNEBACTERIUM PARVUM]. J Reticuloendothel Soc (1964) 3.93
Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect Immun (1986) 3.42
Sensitivity of mice to endotoxin after vaccination with BCG (Bacillus Calmette-Guérin). Proc Soc Exp Biol Med (1958) 3.39
Preparation and properties of a standardized lipopolysaccharide from salmonella abortus equi (Novo-Pyrexal). Zentralbl Bakteriol Orig A (1979) 3.08
Migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity. Infect Immun (1973) 2.73
Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production. J Immunol (1983) 2.72
Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon. J Exp Med (1988) 2.61
Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice. Infect Immun (1991) 2.34
Effect of gamma interferon on cachectin expression by mononuclear phagocytes. Reversal of the lpsd (endotoxin resistance) phenotype. J Exp Med (1986) 2.28
Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J Exp Med (1990) 2.25
Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect Immun (1988) 2.23
Capacity of recombinant gamma interferon to activate macrophages for Salmonella-killing activity. Infect Immun (1989) 2.20
Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse. J Natl Cancer Inst (1977) 2.15
The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxim. J Infect Dis (1980) 2.11
Effects of interferon-gamma and tumor necrosis factor-alpha on the expression of an Ia antigen on a murine macrophage cell line. J Immunol (1986) 2.10
Relative ability of mitogens to stimulate production of interferon by lymphoid cells and to induce suppression of the in vitro immune response. Proc Soc Exp Biol Med (1977) 2.07
The role of IFN-gamma in the pathology of experimental endotoxemia. J Immunol (1990) 2.04
Production of interferon-gamma during infection of mice with Plasmodium chabaudi chabaudi. Immunobiology (1989) 1.99
Monoclonal antibodies against murine gamma interferon. Proc Natl Acad Sci U S A (1984) 1.95
Does endotoxin cause both the disease and parasite death in acute malaria and babesiosis? Lancet (1978) 1.91
Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses. J Exp Med (1982) 1.81
Interferon gamma and lymphotoxin or tumor necrosis factor act synergistically to induce macrophage killing of tumor cells and schistosomula of Schistosoma mansoni. J Exp Med (1987) 1.75
BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. I. In vivo studies. J Immunol (1980) 1.74
Gamma interferon priming of mouse and human macrophages for induction of tumor necrosis factor production by bacterial lipopolysaccharide. J Natl Cancer Inst (1987) 1.64
Bacterial lipopolysaccharide-induced interferon-gamma production: roles of interleukin 1 and interleukin 2. J Immunol (1986) 1.64
Interferon-gamma induction by lipopolysaccharide: dependence on interleukin 2 and macrophages. J Immunol (1986) 1.62
Biological activities of synthetic lipid A analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate. Infect Immun (1984) 1.59
Production of immune interferon by murine T-cell clones from long-term cultures. Nature (1981) 1.45
Immune (gamma) interferon produced by a human T-lymphoblast cell line. Nature (1981) 1.45
Induction of hyperreactivity to endotoxin in mice by Coxiella burnetii. Infect Immun (1984) 1.36
Production of tumor necrosis factor by rIFN-gamma-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins. J Immunol (1988) 1.32
Characterization of a congenitally LPS-resistant, athymic mouse strain. J Immunol (1979) 1.32
Recombinant interferons increase macrophage Fc receptor capacity. J Immunol (1984) 1.25
Interferon-gamma overcomes glucocorticoid suppression of cachectin/tumor necrosis factor biosynthesis by murine macrophages. J Clin Invest (1990) 1.17
Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-2, interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and IL-6 on the production of immunoreactive IL-1 and TNF-alpha by human monocytes. Clin Exp Immunol (1991) 1.17
Gamma interferon production in endotoxin-responder and -nonresponder mice during infection. Infect Immun (1991) 1.11
Endotoxin-induced interferon-gamma production in culture cells derived from BCG-infected C3H/HeJ mice. J Immunol (1988) 1.08
Mitogenic activities of synthetic lipid A analogs and suppression of mitogenicity of lipid A. Infect Immun (1984) 1.06
Interleukins and the immune system 2. Lancet (1989) 1.05
Quantitative determination of hemoglobin and cytochemical staining for peroxidase using 3,3',5,5'-tetramethylbenzidine dihydrochloride, a safe substitute for benzidine. Anal Biochem (1979) 0.97
Increased toxicity of endotoxin for tumor-bearing mice and mice responding to bacterial pathogens: macrophage activation as a common denominator. Infect Immun (1980) 0.95
Quantitation and biological activities of native tumour necrosis factor from LPS-stimulated human monocytes. APMIS (1990) 0.79
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science (1998) 37.15
A new method for the extraction of R lipopolysaccharides. Eur J Biochem (1969) 22.41
Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci U S A (1979) 6.77
Electrodialysis of lipopolysaccharides and their conversion to uniform salt forms. Eur J Biochem (1975) 5.29
The mitogenic effect of lipopolysaccharide on bone marrow-derived mouse lymphocytes. Lipid A as the mitogenic part of the molecule. J Exp Med (1973) 4.74
Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med (1987) 4.63
Picogram-sensitive assay for endotoxin: gelation of Limulus polyphemus blood cell lysate induced by purified lipopolysaccharides and lipid A from Gram-negative bacteria. Biochim Biophys Acta (1972) 4.45
Interaction of lipopolysaccharides and lipid A with complement. Eur J Biochem (1971) 4.15
Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides. Eur J Biochem (1971) 4.01
Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur J Biochem (1985) 3.76
The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen. J Exp Med (1975) 3.55
Structural relationship of Salmonella O and R antigens. Ann N Y Acad Sci (1966) 3.54
Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect Immun (1986) 3.42
Preparation and properties of a standardized lipopolysaccharide from salmonella abortus equi (Novo-Pyrexal). Zentralbl Bakteriol Orig A (1979) 3.08
Biological activities of lipid A complexed with bovine-serum albumin. Eur J Biochem (1972) 3.04
Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice. Infect Immun (1991) 2.34
Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect Immun (1988) 2.23
Differential determination of the 3-Deoxy-D-mannooctulosonic acid residues in lipopolysaccharides of Salmonella minnesota rough mutants. Eur J Biochem (1983) 2.12
Granulocyte activation by endotoxin. I. Correlation between adherence and other granulocyte functions, and role of endotoxin structure on biologic activity. J Immunol (1983) 2.06
Modification of the silver staining technique to detect lipopolysaccharide in polyacrylamide gels. J Clin Microbiol (1990) 2.02
Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats. Infect Immun (1980) 1.85
Lipid A: chemical structure and biological activity. J Infect Dis (1973) 1.73
Diurnal variations in the human host response to endotoxin. J Infect Dis (1996) 1.71
Chemical structure and biological activities of lipid A's from various bacterial families. Naturwissenschaften (1978) 1.69
The role of the physical state of lipopolysaccharides in the interaction with complement. High molecular weight as prerequisite for the expression of anti-complementary activity. Eur J Biochem (1976) 1.64
Biological activities of synthetic lipid A analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate. Infect Immun (1984) 1.59
Physical state and biological activity of lipopolysaccharides. Toxicity and immunogenicity of the lipid A component. Z Immunitatsforsch Exp Klin Immunol (1975) 1.55
Mechanisms of endotoxin shock and endotoxin hypersensitivity. Immunobiology (1993) 1.54
Time course of cellular distribution of endotoxin in liver, lungs and kidneys of rats. Br J Exp Pathol (1982) 1.54
Immunogenic properties of lipid A. Rev Infect Dis (1984) 1.51
A lipopolysaccharide-binding cell-surface protein from Salmonella minnesota. Isolation, partial characterization and occurrence in different Enterobacteriaceae. Eur J Biochem (1979) 1.49
Comparative immunochemistry of lipopolysaccharides from typable and polyagglutinable Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis. J Clin Microbiol (1988) 1.46
Isolation, purification, and chemical analysis of the lipopolysaccharide and lipid A of Acinetobacter calcoaceticus NCTC 10305. Eur J Biochem (1982) 1.39
Pyrogenicity and immunogenicity of lipid A complexed with bovine serum albumin or human serum albumin. Infect Immun (1973) 1.38
Nontoxic lipopolysaccharide from Rhodopseudomonas sphaeroides ATCC 17023. J Bacteriol (1983) 1.37
Biological activities of chemically modified endotoxins. Eur J Biochem (1971) 1.36
Induction of hyperreactivity to endotoxin in mice by Coxiella burnetii. Infect Immun (1984) 1.36
Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity. Prog Clin Biol Res (1987) 1.35
Endotoxic properties of chemically synthesized lipid A part structures. Comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A. Eur J Biochem (1984) 1.33
Macrophage factor controlling differentiation of B cells. J Immunol (1979) 1.28
Bacterial induction of beta interferon in mice is a function of the lipopolysaccharide component. Infect Immun (2000) 1.27
Phase II trial of intravenous endotoxin in patients with colorectal and non-small cell lung cancer. Eur J Cancer (1996) 1.26
Dose-dependent effects of endotoxin on human sleep. Am J Physiol Regul Integr Comp Physiol (2000) 1.26
Lipid A antiserum-mediated protection against lipopolysaccharide- and lipid A-induced fever and skin necrosis. Infect Immun (1977) 1.23
Lipopolysaccharides: structural principles and biologic activities. Rev Infect Dis (1984) 1.22
Biological activities of lipopolysaccharides and lipid A from Rhodospirillaceae. Infect Immun (1977) 1.21
The occurrence of 4-amino-4-deoxy-L-arabinose as a constituent in Salmonella lipopolysaccharide preparations. Eur J Biochem (1970) 1.20
Common lipopolysaccharide specificity: new type of antigen residing in the inner core region of S- and R-form lipopolysaccharides from different families of gram-negative bacteria. Infect Immun (1983) 1.18
Lipid A, the active part of bacterial endotoxins in inducing serum colony stimulating activity and proliferation of splenic granulocyte/macrophage progenitor cells. J Cell Physiol (1976) 1.17
ELISA for antibodies to lipid A, lipopolysaccharides and other hydrophobic antigens. Infection (1990) 1.17
Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. Infect Immun (1988) 1.17
Phase I trial of intravenously administered endotoxin (Salmonella abortus equi) in cancer patients. Cancer Res (1991) 1.16
Induction of hypersensitivity to endotoxin and tumor necrosis factor by sublethal infection with Salmonella typhimurium. Infect Immun (1990) 1.16
A point mutation in the IL-12R beta 2 gene underlies the IL-12 unresponsiveness of Lps-defective C57BL/10ScCr mice. J Immunol (2001) 1.15
Endotoxins of Gram-negative bacteria. Pharmacol Ther (1981) 1.14
Analysis of bypass activation of C3 by endotoxic LPS and loss of this potency. Immunology (1973) 1.13
Biological activity of synthetic heptaacyl lipid A representing a component of Salmonella minnesota R595 lipid A. Eur J Biochem (1986) 1.12
Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists. Cell Death Differ (2013) 1.12
Gamma interferon production in endotoxin-responder and -nonresponder mice during infection. Infect Immun (1991) 1.11
B-cell activation by lipopolysaccharide. Distinct pathways for induction of mitosis and antibody production. J Exp Med (1977) 1.11
Chemical, physicochemical and biological properties of bacterial lipopolysaccharides. Prog Clin Biol Res (1979) 1.09
Mechanisms of chemical-induced innate immunity in allergic contact dermatitis. Allergy (2011) 1.08
Differences in innate defense mechanisms in endotoxemia and polymicrobial septic peritonitis. Infect Immun (2001) 1.08
Pleiotropic defects of IL-6-deficient mice including early hematopoiesis, T and B cell function, and acute phase responses. Ann N Y Acad Sci (1995) 1.08
Mitogenic activities of synthetic lipid A analogs and suppression of mitogenicity of lipid A. Infect Immun (1984) 1.06
Comparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strains. Infect Immun (1991) 1.06
Growing tumors induce hypersensitivity to endotoxin and tumor necrosis factor. Infect Immun (1987) 1.06
Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis. Lancet (1989) 1.05
Fatty acid alterations and polymyxin B binding by lipopolysaccharides from Pseudomonas aeruginosa adapted to polymyxin B resistance. Antimicrob Agents Chemother (1989) 1.05
Inherited IL-12 unresponsiveness contributes to the high LPS resistance of the Lps(d) C57BL/10ScCr mouse. J Immunol (2001) 1.04
Structural and physicochemical requirements of endotoxins for the activation of arachidonic acid metabolism in mouse peritoneal macrophages in vitro. Eur J Biochem (1989) 1.04
Circulating lipid A antibodies despite absence of systemic endotoxemia in patients with Crohn's disease. Dig Dis Sci (1984) 1.04
Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in mice. Gastroenterology (1995) 1.04
Analysis of LPS released from Salmonella abortus equi in human serum. Microb Pathog (1991) 1.04
Enhancement of endotoxin lethality and generation of anaphylactoid reactions by lipopolysaccharides in muramyl-dipeptide-treated mice. Infect Immun (1987) 1.03
Role of lipopolysaccharide susceptibility in the innate immune response to Salmonella typhimurium infection: LPS, a primary target for recognition of Gram-negative bacteria. Microbes Infect (2001) 1.03
A new lipopolysaccharide antigen identified in Acinetobacter calcoaceticus: occurrence of widespread natural antibody. J Med Microbiol (1983) 1.02
Recent findings on the chemical structure and biological activity of bacterial lipopolysaccharides. J Hyg Epidemiol Microbiol Immunol (1974) 1.02
Infection of C57BL/10ScCr and C57BL/10ScNCr mice with Leishmania major reveals a role for Toll-like receptor 4 in the control of parasite replication. J Leukoc Biol (2004) 1.02
A 14,000 MW lipoprotein and a glycolipid-like structure of Borrelia burgdorferi induce proliferation and immunoglobulin production in mouse B cells at high frequencies. Immunology (1994) 1.02
Distribution and localization of endotoxin in the reticulo-endothelial system (RES) and in the main vessels of the rat during shock. Pathol Res Pract (1985) 1.02
The fate of lipopolysaccharide in rats: evidence for chemical alteration in the molecule. Rev Infect Dis (1984) 1.02
Endotoxic properties of synthetic pentaacyl lipid A precursor Ib and a structural isomer. Eur J Biochem (1987) 1.00